Steven Luzio

Suggest Changes
Learn More
OBJECTIVE To compare pharmacokinetics and pharmacodynamics of insulin analogs glargine and detemir, 24 subjects with type 1 diabetes (aged 38 +/- 10 years, BMI 22.4 +/- 1.6 kg/m2, and A1C 7.2 +/-(More)
Objective. To compare pharmacokinetics and -dynamics (PD) of insulin glargine (GLA) and detemir (DET), 24 subjects with T1DM (38±10 years, BMI 22.4±1.6, kg/m, HbA1c 7.2±0.7%, mean±SD) were studied(More)
  • 1